Published in EMBO J on September 01, 1991
Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J (1992) 5.23
Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res (1995) 2.33
Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J (1997) 1.70
Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol (1993) 1.70
The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J Cell Biol (1999) 1.48
Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol Cell Biol (1995) 1.47
Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell (2003) 1.46
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway. Oncogene (2011) 1.42
HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J (1996) 1.39
Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev (2000) 1.33
Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis (2002) 1.33
Induction of apoptosis by c-Fos protein. Mol Cell Biol (1996) 1.26
Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc Natl Acad Sci U S A (1992) 1.25
Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle. Mol Cell Biol (1994) 1.22
TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol Cell Biol (1993) 1.16
Cartilage homeoprotein 1, a homeoprotein selectively expressed in chondrocytes. Proc Natl Acad Sci U S A (1993) 1.09
Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol (1994) 1.06
Transrepression of RNA polymerase II promoters by the simian virus 40 small t antigen. J Virol (1994) 1.02
Animal models of typical heterotopic ossification. J Biomed Biotechnol (2010) 1.00
Degeneration of neural cells in the central nervous system of mice deficient in the gene for the adhesion molecule on Glia, the beta 2 subunit of murine Na,K-ATPase. J Cell Biol (1994) 0.98
Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice. Int J Cancer (2011) 0.88
A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines. Invest New Drugs (2007) 0.87
Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors. BMC Cancer (2010) 0.86
c-Fos/activator protein-1 transactivates wee1 kinase at G(1)/S to inhibit premature mitosis in antigen-specific Th1 cells. EMBO J (2001) 0.84
C-Fos regulation by the MAPK and PKC pathways in intervertebral disc cells. PLoS One (2013) 0.84
EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice. J Clin Invest (2013) 0.83
c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1. World J Gastroenterol (2008) 0.83
Chondrocytes as a specific target of ectopic Fos expression in early development. Proc Natl Acad Sci U S A (1997) 0.81
Small molecule inhibitors targeting activator protein 1 (AP-1). J Med Chem (2014) 0.81
Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene. Infect Immun (2001) 0.80
Transplantation of cultured small bowel enterocytes. Gut (1993) 0.79
Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma. J Clin Endocrinol Metab (2011) 0.79
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1. Oncogene (2015) 0.76
Substituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1. BMC Pharmacol (2008) 0.75
cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma. Stem Cell Reports (2017) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21
Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell (1986) 9.10
The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell (1988) 6.75
Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science (1990) 6.72
Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature (1984) 6.54
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell (1984) 5.55
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (1988) 5.04
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44
The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science (1988) 4.15
Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell (1988) 4.13
Transcriptional autoregulation of the proto-oncogene fos. Nature (1988) 4.10
Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos. Cell (1987) 3.89
Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature (1988) 3.43
Virus induction of osteosarcomas in mice. Science (1966) 2.96
The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell (1989) 2.84
Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol (1990) 2.82
Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol (1988) 2.73
Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell (1988) 2.36
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34
Genetics of human cancer. Annu Rev Genet (1986) 2.28
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
Oncogenic conversion by regulatory changes in transcription factors. Cell (1991) 2.11
Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08
Transcriptional activation encoded by the v-fos gene. Proc Natl Acad Sci U S A (1986) 1.99
c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell (1986) 1.87
Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature (1990) 1.81
Dissecting multistep tumorigenesis in transgenic mice. Annu Rev Genet (1988) 1.79
The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription. Oncogene (1989) 1.78
Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev Biol (1990) 1.61
FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes. Virology (1984) 1.53
Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. EMBO J (1985) 1.48
Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol (1990) 1.46
c-fos expression induces bone tumors in transgenic mice. Oncogene (1989) 1.40
c-fos expression interferes with thymus development in transgenic mice. Cell (1988) 1.35
Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development (1989) 1.29
Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products. Biochim Biophys Acta (1986) 1.28
Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development (1988) 1.25
Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. Dev Biol (1990) 1.17
Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue. Nature (1987) 1.15
Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol (1988) 1.15
The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene (1990) 1.14
Expression of c-fos in parietal endoderm, amnion and differentiating F9 teratocarcinoma cells. Differentiation (1985) 1.06
Formation of germ-line chimeras from embryonic stem cells maintained with recombinant leukemia inhibitory factor. Exp Cell Res (1990) 0.87
c-fos expression precedes osteogenic differentiation of cartilage cells in vitro. J Cell Biol (1990) 0.85
EMBO medal review. On transferring genes into stem cells and mice. EMBO J (1990) 0.83
The proto-oncogene c-fos: structure, expression, and functional aspects. Oxf Surv Eukaryot Genes (1989) 0.81
Characterization of fos-induced osteogenic tumours and tumour-derived murine cell lines. Differentiation (1990) 0.79
The specific consequences of c-fos expression in transgenic mice. Prog Nucleic Acid Res Mol Biol (1989) 0.79
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (1985) 7.54
c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (1994) 5.97
Strain-dependent epithelial defects in mice lacking the EGF receptor. Science (1995) 5.22
Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature (1997) 5.08
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev (1995) 4.54
Bone and haematopoietic defects in mice lacking c-fos. Nature (1993) 4.07
AP-1 in mouse development and tumorigenesis. Oncogene (2001) 3.93
Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell (1994) 3.91
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51
c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43
Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet (1999) 3.42
Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol (1999) 3.29
PARP is important for genomic stability but dispensable in apoptosis. Genes Dev (1997) 3.20
The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc Natl Acad Sci U S A (1981) 2.93
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell (1990) 2.77
Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Acad Child Adolesc Psychiatry (1996) 2.69
Transfer of genes into embryonal carcinoma cells by retrovirus infection: efficient expression from an internal promoter. EMBO J (1985) 2.60
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol (1999) 2.60
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development (2000) 2.43
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med (2000) 2.36
Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell (1988) 2.36
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J (2001) 2.32
The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell (2000) 2.22
Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J (1987) 2.16
Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell (1989) 2.14
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
A universal retroviral vector for efficient constitutive expression of exogenous genes. Nucleic Acids Res (1987) 2.11
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res (1996) 2.09
Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08
The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med (1997) 2.07
JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J (2000) 2.05
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature (1994) 2.03
Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med (1999) 1.98
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet (2000) 1.96
A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J (1998) 1.86
Functions of c-Jun in liver and heart development. J Cell Biol (1999) 1.85
The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell (2000) 1.81
c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med (2001) 1.81
Clustered homeo boxes are differentially expressed during murine development. Cell (1985) 1.80
Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell (2001) 1.79
Fos is an essential component of the mammalian UV response. EMBO J (1995) 1.73
Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J (1997) 1.70
Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol (1993) 1.70
Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev (1997) 1.69
Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. Arch Gen Psychiatry (1991) 1.65
Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64
Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line. Cell (1983) 1.63
Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells. Proc Natl Acad Sci U S A (1980) 1.58
JunB is essential for mammalian placentation. EMBO J (1999) 1.57
Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem (1995) 1.56
Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat Genet (1997) 1.52
Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J (1987) 1.51
Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. EMBO J (1985) 1.48
Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ (1995) 1.46
Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol (1990) 1.46
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene (2000) 1.45
c-fos expression induces bone tumors in transgenic mice. Oncogene (1989) 1.40
Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development (2001) 1.38
c-fos expression interferes with thymus development in transgenic mice. Cell (1988) 1.35
Placental vascularisation requires the AP-1 component fra1. Development (2000) 1.34
Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev (2000) 1.33
Gene transfer into murine stem cells and mice using retroviral vectors. Cold Spring Harb Symp Quant Biol (1985) 1.27
Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci U S A (1990) 1.24
c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res (1995) 1.24
Early fetal hematopoietic development from in vitro differentiated embryonic stem cells. New Biol (1991) 1.23
Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. Am J Pathol (1993) 1.22
Transfer of nonselectable genes into mouse teratocarcinoma cells and transcription of the transferred human beta-globin gene. Mol Cell Biol (1982) 1.19
Protective role of Raf-1 in Salmonella-induced macrophage apoptosis. J Exp Med (2001) 1.19
c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol Cell Biol (2000) 1.18
Control of phosphoenolpyruvate-dependent phosphotransferase-mediated sugar transport in Escherichia coli by energization of the cell membrane. Proc Natl Acad Sci U S A (1979) 1.16
Expression of human alpha 1-acid glycoprotein genes in cultured cells and in transgenic mice. Genes Dev (1988) 1.15
Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia (2001) 1.14
Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol Cell Biol (1992) 1.14
Expression of functional human EGF receptor on murine bone marrow cells. EMBO J (1988) 1.13
Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene. J Cell Sci (2000) 1.11
Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene (1995) 1.09
Jun and JunD-dependent functions in cell proliferation and stress response. Cell Death Differ (2010) 1.09
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J Cell Biol (2000) 1.08
Oncogenic properties of the middle T antigens of polyomaviruses. Adv Cancer Res (1994) 1.07
Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol (1994) 1.06
Development of Escherichia coli virus T1. The role of the proton-motive force. J Biol Chem (1980) 1.05
Antagonistic control of cell fates by JNK and p38-MAPK signaling. Cell Death Differ (2007) 1.04
The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice. Oncogene (2008) 1.03
Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase. Oncogene (1997) 1.03
Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. Oncogene (1992) 1.01